Cannabis and depression: An integrative data analysis of four Australasian cohorts

Drug and Alcohol Dependence

Volumn 126, Issue 3, 2012, Pages 369-378

  Horwood, L John ^a   Fergusson, David M ^a   Coffey, Carolyn ^b   Patton, George C ^b   Tait, Robert ^c   Smart, Diana ^d   Letcher, Primrose ^b   Silins, Edmund ^e   Hutchinson, Delyse M ^e  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^d AUSTRALIAN INSTITUTE OF FAMILY STUDIES   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cannabis; Depression; Integrative data analysis; Longitudinal study

Indexed keywords

CANNABIS;

ADOLESCENCE; ADOLESCENT; ADULT; ADULTHOOD; AGE; ARTICLE; AUSTRALIA; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM;

ADOLESCENT; ADULT; AUSTRALIA; DEPRESSION; HUMANS; LONGITUDINAL STUDIES; MARIJUANA ABUSE; MIDDLE AGED; NEW ZEALAND; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; YOUNG ADULT;

CANNABIS;

EID: 84869204061     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.06.002     Document Type: Article

References (64)

1. Andreasson S., Allebeck P., Engstrom A., Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987, 330:1483-1486.
2. Angold A., Costello E.J., Messer S.J., Pickles A., Winder F., Silver D. Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. Int. J. Meth. Psychiatric Res. 1995, 5:237-249.
3. Anstey K.J., Christensen H., Butterworth P., Easteal S., Mackinnon A., Jacomb T., Maxwell K., Rodgers B., Windsor T., Cherbuin N., Jorm A.F. Cohort profile: the PATH through life project. J. Epidemiol. 2011, (Epub ahead of print).
4. Arendt M., Rosenberg R., Fjordback L., Brandholdt J., Foldager L., Sher L., Munk-Jorgensen P. Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects. Psychol. Med. 2007, 37:935-945.
5. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br. Med. J. 2002, 325:1212-1213.
6. Baltagi B.H. Econometric Analysis of Panel Data 2005, J. Wiley & Sons, Chichester, Hoboken, NJ.
7. Beautrais A.L., Joyce P., Mulder R. Cannabis abuse and serious suicide attempts. Addiction 1999, 94:1155-1164.
8. 11C]WAY-100635. Mol. Psychiatry 2004, 9:386-392.
9. Boden J.M., Fergusson D.M., Horwood L.J. Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br. J. Psychiatry 2010, 196:440-446.
10. Borges G., Walters E., Kessler R.C. Associations of substance use, abuse and dependence with subsequent suicidal behaviour. Am. J. Epidemiol. 2000, 151:781-789.
11. Bovasso G. Cannabis abuse as a risk factor for depressive symptoms. Am. J. Psychiatry 2001, 158:2033-2037.
12. Chen C., Wagner F., Anthony J. Marijuana use and the risk of major depressive episode: epidemiological evidence from the United States National Comorbidity Survey. Soc. Psychol. Psychiatric Epidemiol. 2002, 37:199-206.
13. Cheung J.T.W., Mann R.E., Ialomiteanu A., Stoduto G., Chan V., Ala-Leppilampi K., Rehm J. Anxiety and mood disorders and cannabis use. Am. J. Drug Alcohol Abuse 2010, 36:118-122.
14. Costello A., Edelbrock C., Kalas R., Kessler M., Klaric S.A. Diagnostic Interview Schedule for Children (DISC) 1982, National Institute of Mental Health, Bethesda, MD.
15. 3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 2001, 103:9-15.
16. Degenhardt L., Hall W., Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003, 98:1493-1504.
17. Degenhardt L., Hall W., Lynskey M. Testing the hypotheses about the relationship between cannabis and psychosis. Drug Alcohol Depend. 2003, 71:37-48.
18. Di Forti M., Morgan C., Dazzan P., Pariante C., Mondelli V., Marques T.R., Handley R., Luzi S., Russo M., Paparelli A., Butt A., Stilo S.A., Wiffen B., Powell J., Murray R.M. High-potency cannabis and the risk of psychosis. Br. J. Psychiatry 2009, 195. 488-449.
19. Drevets W., Frank E., Price J., Kupfer D., Holt D., Greer P., Huang Y., Gautier C., Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry 1999, 46:1375-1387.
20. Eggan S.M., Mizoguchi Y., Stoyak S.R., Lewis D.A. Development of cannabinoid 1 receptor. Protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cereb. Cortex 2010, 20:1164-1174.
21. Fergusson D.M., Boden J.M., Horwood L.J. The developmental antecedents of illicit drug use: evidence from a 25-year longitudinal study. Drug Alcohol Depend. 2008, 96:165-177.
22. Fergusson D.M., Boden J.M., Horwood L.J. Tests of causal linkages between alcohol abuse or dependence and major depression. Arch. Gen. Psychiatry 2009, 66:260-266.
23. Fergusson D.M., Horwood L.J. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997, 92:279-296.
24. Fergusson D.M., Horwood L.J. The Christchurch Health and Development Study: review of findings on child and adolescent mental health. Aust. N. Z. J. Psychiatry 2001, 35:287-296.
25. Fergusson D.M., Horwood L.J., Ridder E.M. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 2005, 100:354-366.
26. Fergusson D.M., Horwood L.J., Shannon F.T., Lawton J.M. The Christchurch Child Development Study: a review of epidemiological findings. Paediatr. Perinat. Epidemiol. 1989, 3:302-325.
27. Fergusson D.M., Horwood L.J., Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002, 97:1123-1135.
28. Goldberg D., Bridges K., Duncan-Jones P., Grayson D. Detecting anxiety and depression in general medical settings. Br. Med. J. 1988, 297:897-899.
29. Green B., Kavanagh D., Young R. Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev. 2003, 22:453-460.
30. Greene W.H. Econometric Analysis 2003, Prentice Hall, Upper Saddle River, NJ.
31. Han B., Gfroerer J.C., Colliver J. Associations between duration of illicit drug use and health conditions: results from the 2005-2007 National Surveys on Drug Use and Health. Ann. Epidemiol. 2010, 20:289-297.
32. Harder V., Stuart E., Anthony J. Adolescent cannabis problems and young adult depression: male-female stratified propensity score analyses. Am. J. Epidemiol. 2008, 168:592-601.
33. Hayatbakhsh M.R., Najman J.M., Jamrozik K., Mamun A.A., Alati R., Bor W. Cannabis and anxiety and depression in young adults: a large prospective study. J. Am. Acad. Child Adolesc. Psychiatry 2007, 46:408-417.
34. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U., van Os J. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. Br. Med. J. 2005, 330:11.
35. Hill M., Sun J., Tse M., Gorzalka B. Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment. Int. J. Neuropsychopharmacol. 2006, 9:277-286.
36. Jablensky A., McGrath J., Herrman H., Castle D., Gureje O., Evans M., Carr V., Morgan V., Korten A., Harvey C. Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Aust. N. Z. J. Psychiatry 2000, 34:221-236.
37. Klien D.N., Riso L.P. Psychiatric disorders: problems of boundaries and comorbidity. Basic Issues in Psychopathology 1994, 19-66. Guilford Press, New York. G. Costello (Ed.).
38. Kuepper R., van Os J., Lieb R., Wittchen H.U., Hofler M., Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. Br. Med. J. 2011, 342:d738.
39. Large M., Swapnil S., Compton M., Slate T., Nielsson O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch. Gen. Psychiatry 2011, 68:555-561.
40. Leroy S., Griffon N., Bourdel M., Olie J., Poirer M., Krebs M. Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. Am. J. Med. Genet. 2001, 105:749-752.
41. Lewis G., Pelosi A.J., Glover E., Wilkinson G., Stansfeld S.A., Williams P., Shepard M. The development of a computerized assessment for minor psychiatric disorder. Psychol. Med. 1988, 18:737-745.
42. Lovibond S.H., Lovibond P.F. Manual for the Depression Anxiety Stress Scales 1995, Psychology Foundation, Sydney. 2nd ed.
43. Lynskey M., Glowinski A., Todorov A., Bucholz K., Madden P., Nelson E., Statham D., Martin N., Heath A. Major depressive disorder, suicidal ideation, and suicide attempts in twins discordant for cannabis dependence and early-onset cannabis use. Arch. Gen. Psychiatry 2004, 61:1026-1032.
44. Macleod J., Oakes R., Copello A., Crome I., Egger M., Hickman M., Oppenkowski T., Stokes-Lampard H., Smith G. Psychological and social sequelae of cannabis and other illicit drug use by young people: a asystematic review of longitudinal, general population studies. Lancet 2004, 363:1579-1588.
45. Malone D.T., Hill M.N., Rubino T. Adolescent cannabis and psychosis: epidemiology and neurodevelopmental models. Br. J. Pharmacol. 2010, 160:511-522.
46. Marmorstein N., Iacono W. Explaining associations between cannabis use disorders in adolescnece and later major depression: a test of the psychosocial failure model. Addict. Behav. 2011, 36:773-776.
47. McGee R., Williams S., Poulton R., Moffitt T. A longitudinal study of cannabis use and mental health from adolescence to early adulthoood. Addiction 2000, 95:491-503.
48. Patton G., Coffey C., Carlin J., Degenhardt L., Lynskey M., Hall W. Cannabis use and mental health in young people: cohort study. Br. Med. J. 2002, 325:1195-1198.
49. Patton G.C., Coffey C., Lynskey M., Reid S., Hemphill S., Carlin J.B., Hall W. Trajectories of adolescent alcohol and cannabis use into young adulthood. Addiction 2007, 102:607-615.
50. Pedersen W. Does cannabis use lead to depression and suicidal behaviours? A population-based longitudinal study. Acta Psychiatrica Scand. 2008, 118:395-403.
51. Prior M., Sanson A., Smart D., Oberklaid F. Pathways from Infancy to Adolescence: Australian Temperament Project 1983-2000 2000, Australian Institute of Family Studies, Melbourne.
52. Rey J.M., Sawyer M.G., Raphael B., Patton G.C., Lynskey M. Mental health of teenagers who use cannabis. Br. J. Psychiatry 2002, 180.
53. Sanson A., Prior M., Oberklaid F. Normative data on temperament in Australian infants. Aust. J. Psychol. 1985, 37:185-195.
54. 11C]WAY-100635: effects of depression and antidepression treatment. Arch. Gen. Psychiatry 2000, 57:174-180.
55. Schneider M. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict. Biol. 2008, 13:253-263.
56. Solowij N., Battisti R. The chronic effects of cannabis on memory in humans: a review. Curr. Drug Abuse Rev. 2008, 1:81-98.
57. StataCorp Stata Statistical Software: Release 10.0 2007, Stata Corporation, College Station, TX.
58. Stefanis N.C., Delespaul P., Henquet C., Bakoula C., Stefanis C.N., van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004, 99:1333-1341.
59. Tsou K., Mackie K., Sanudo-Pena M.C., Walker J.M. Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 1999, 93:969-975.
60. van Laar M., van Dorsselaer S., Monshouwer K., de Graaf R. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population. Addiction 2007, 102:1251-1260.
61. van Os J., Bak M., Hanssen M., Bijl R., de Graaf R., Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am. J. Epidemiol. 2002, 156:319-327.
62. World Health Organization Composite International Diagnostic Interview (CIDI) 1993, World Health Organization, Geneva, Switzerland.
63. Zammit S., Allebeck P., Andreasson S., Lundberg I., Lewis G. Self-reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br. Med. J. 2002, 325:1199-1201.
64. Zvolensky M.J., Cougle J., Johnson K., Bonn-Miller M. Marijuana use and panic psychopathology among a representative sample of adults. Exp. Clin. Psychopharmacol. 2010, 18:129-134.